Search Results 31-40 of 16722 for GLP-1 agonists
The purpose of this study is to determine the effects of blocking the receptors of the Glucagon-like Peptide-1 (GLP-1) hormone after different types of ...
Using combined therapy to treat obesity, combining bariatric surgery, also called metabolic surgery, with GLP-1 medications. Learn more.
Two diabetes prescriptions that have benefits beyond lowering blood sugar are GLP-1 receptor agonist (GLP-1RA) and SGLT2 inhibitor (SGLT2i) medications. For ...
... glucagon-like peptide 1 (GLP-1) agonists due to their additional benefits in glucose management. Guidance for ...
Regional gut transit delays on glucagon-like peptide-1 agonists in relation to clinical and pharmacologic factors. Clin Gastroenterol Hepatol (In press). 2025.
... GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors. Ann Intern Med. 2018 Jul 17; 169 (2):JC2 View PubMed; Egan AM, Montori VM. Review: In adults ...
The purpose of this study is to determine the contribution of islet GLP-1 to islet function in people with and without diabetes-associated genetic variation in ...
The purpose of this study is to determine the contribution of islet GLP-1 to islet function in prediabetes. Participation eligibility. Participant ...
Also approved by the FDA is a class of drugs known as glucagonlike peptide 1 agonists, also called GLP-1 agonists. Some of these medicines are approved ...
Glucagon-like peptide 1 (GLP-1) receptor agonists such as semaglutide ... If you have this procedure done on one eye, you may notice improvement in both eyes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.